Article info
Clinical ethics
Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material
- Correspondence to: Mr S Enoch Wound Healing Research Unit, University Department of Surgery, Medicentre, University of Wales College of Medicine, Cardiff CF14 4UJ, UK; enochstuarthotmail.com
Citation
Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material
Publication history
- Received June 12, 2003
- Accepted August 7, 2003
- Revised July 30, 2003
- First published January 5, 2005.
Online issue publication
January 05, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Palliative care in Creutzfeldt-Jakob disease: looking back, thinking ahead
- Presenile dementia syndromes: an update on taxonomy and diagnosis
- Genetics of the dementias
- How to select a biosimilar
- Neuroimaging findings in human prion disease
- Dura mater-associated Creutzfeldt–Jakob disease: experience from surveillance in the UK
- Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases
- Molecular neurology of prion disease
- What's new this month in BMJ Journals
- Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease